发明授权
US07820670B2 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions
有权
6-氨基咪唑并[1,2-b]哒嗪类似物作为rho激酶抑制剂,用于治疗rho激酶介导的疾病和病症
- 专利标题: 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions
- 专利标题(中): 6-氨基咪唑并[1,2-b]哒嗪类似物作为rho激酶抑制剂,用于治疗rho激酶介导的疾病和病症
-
申请号: US11960476申请日: 2007-12-19
-
公开(公告)号: US07820670B2公开(公告)日: 2010-10-26
- 发明人: Hwang-Hsing Chen , Andrew Rusinko , Mark R. Hellberg , Bryon S. Severns , Alan J. Henderson , Cheng Guo , Mark Hadden
- 申请人: Hwang-Hsing Chen , Andrew Rusinko , Mark R. Hellberg , Bryon S. Severns , Alan J. Henderson , Cheng Guo , Mark Hadden
- 申请人地址: US TX Fort Worth
- 专利权人: Alcon Research, Ltd.
- 当前专利权人: Alcon Research, Ltd.
- 当前专利权人地址: US TX Fort Worth
- 代理商 Mark E. Flanigan
- 主分类号: A61K31/501
- IPC分类号: A61K31/501
摘要:
Methods for using 6-aminoimidazo[1,2-b]pyridazine analogs are disclosed herein to treat rho kinase-mediated diseases or rho kinase-mediated conditions, including controlling intraocular pressure and treating glaucoma, are disclosed. Ophthalmic pharmaceutical compositions useful in the treatment of eye diseases such as glaucoma, and additionally useful for controlling intraocular pressure, the compositions comprising an effective amount of 6-aminoimidazo[1,2-b]pyridazine analogs, are disclosed herein.
公开/授权文献
信息查询
IPC分类: